These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1402 related articles for article (PubMed ID: 25869964)

  • 1. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A; Salmaso S; Eldar-Boock A; Ben-Shushan D; Ferber S; Tiram G; Shmeeda H; Landa-Rouben N; Leor J; Caliceti P; Gabizon A; Satchi-Fainaro R
    J Control Release; 2015 Jun; 208():106-20. PubMed ID: 25869964
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel folated and non-folated pullulan bioconjugates for anticancer drug delivery.
    Scomparin A; Salmaso S; Bersani S; Satchi-Fainaro R; Caliceti P
    Eur J Pharm Sci; 2011 Apr; 42(5):547-58. PubMed ID: 21371555
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models.
    Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S
    Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration.
    Riviere K; Huang Z; Jerger K; Macaraeg N; Szoka FC
    J Drug Target; 2011 Jan; 19(1):14-24. PubMed ID: 20353291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate-receptor-targeted delivery of doxorubicin nano-aggregates stabilized by doxorubicin-PEG-folate conjugate.
    Yoo HS; Park TG
    J Control Release; 2004 Nov; 100(2):247-56. PubMed ID: 15544872
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor activity of a folate receptor-targeted immunoglobulin G-doxorubicin conjugate.
    Yang T; Xu L; Li B; Li W; Ma X; Fan L; Lee RJ; Xu C; Xiang G
    Int J Nanomedicine; 2017; 12():2505-2515. PubMed ID: 28408821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and evaluation of a novel ligand for folate-mediated targeting liposomes.
    Xiang G; Wu J; Lu Y; Liu Z; Lee RJ
    Int J Pharm; 2008 May; 356(1-2):29-36. PubMed ID: 18258394
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Folate-functionalized polymeric micelle as hepatic carcinoma-targeted, MRI-ultrasensitive delivery system of antitumor drugs.
    Hong G; Yuan R; Liang B; Shen J; Yang X; Shuai X
    Biomed Microdevices; 2008 Oct; 10(5):693-700. PubMed ID: 18350380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice.
    Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S
    Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improved drug delivery and therapeutic efficacy of PEgylated liposomal doxorubicin by targeting anti-HER2 peptide in murine breast tumor model.
    Zahmatkeshan M; Gheybi F; Rezayat SM; Jaafari MR
    Eur J Pharm Sci; 2016 Apr; 86():125-35. PubMed ID: 26972276
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel cancer targeting approach based on estrone anchored stealth liposome for site-specific breast cancer therapy.
    Paliwal SR; Paliwal R; Mishra N; Mehta A; Vyas SP
    Curr Cancer Drug Targets; 2010 May; 10(3):343-53. PubMed ID: 20370682
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intracellular delivery of redox cycler-doxorubicin to the mitochondria of cancer cell by folate receptor targeted mitocancerotropic liposomes.
    Malhi SS; Budhiraja A; Arora S; Chaudhari KR; Nepali K; Kumar R; Sohi H; Murthy RS
    Int J Pharm; 2012 Aug; 432(1-2):63-74. PubMed ID: 22531856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model.
    Pan XQ; Wang H; Lee RJ
    Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Folate and TAT peptide co-modified liposomes exhibit receptor-dependent highly efficient intracellular transport of payload in vitro and in vivo.
    Zhu Y; Cheng L; Cheng L; Huang F; Hu Q; Li L; Tian C; Wei L; Chen D
    Pharm Res; 2014 Dec; 31(12):3289-303. PubMed ID: 24858397
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vascular targeting of doxorubicin using cationic liposomes.
    Wu J; Lee A; Lu Y; Lee RJ
    Int J Pharm; 2007 Jun; 337(1-2):329-35. PubMed ID: 17275230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Estrogen-anchored pH-sensitive liposomes as nanomodule designed for site-specific delivery of doxorubicin in breast cancer therapy.
    Paliwal SR; Paliwal R; Pal HC; Saxena AK; Sharma PR; Gupta PN; Agrawal GP; Vyas SP
    Mol Pharm; 2012 Jan; 9(1):176-86. PubMed ID: 22091702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantification of DOX bioavailability in biological samples of mice by sensitive and precise HPLC assay.
    Zhang C; Wu Y; Dong Y; Xu H; Zhao L
    Pharm Biol; 2016; 54(1):55-61. PubMed ID: 25880143
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Folate receptor-targeted multimodal polymersomes for delivery of quantum dots and doxorubicin to breast adenocarcinoma: In vitro and in vivo evaluation.
    Alibolandi M; Abnous K; Sadeghi F; Hosseinkhani H; Ramezani M; Hadizadeh F
    Int J Pharm; 2016 Mar; 500(1-2):162-78. PubMed ID: 26802496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Folate-modified poly(2-ethyl-2-oxazoline) as hydrophilic corona in polymeric micelles for enhanced intracellular doxorubicin delivery.
    Qiu LY; Yan L; Zhang L; Jin YM; Zhao QH
    Int J Pharm; 2013 Nov; 456(2):315-24. PubMed ID: 24016742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Water-soluble polymers for targeted drug delivery to human squamous carcinoma of head and neck.
    Nan A; Ghandehari H; Hebert C; Siavash H; Nikitakis N; Reynolds M; Sauk JJ
    J Drug Target; 2005 Apr; 13(3):189-97. PubMed ID: 16036307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 71.